These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 30970533)
1. Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma. Teran-Saavedra NG; Sarabia-Sainz JA; Silva-Campa E; Burgara-Estrella AJ; Guzmán-Partida AM; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L Molecules; 2019 Apr; 24(7):. PubMed ID: 30970533 [TBL] [Abstract][Full Text] [Related]
2. Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma. Thao LQ; Lee C; Kim B; Lee S; Kim TH; Kim JO; Lee ES; Oh KT; Choi HG; Yoo SD; Youn YS Colloids Surf B Biointerfaces; 2017 Apr; 152():183-191. PubMed ID: 28110040 [TBL] [Abstract][Full Text] [Related]
3. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302 [TBL] [Abstract][Full Text] [Related]
4. Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin. Teran-Saavedra NG; Sarabia-Sainz JA; Velázquez-Contreras EF; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L Molecules; 2020 Nov; 25(22):. PubMed ID: 33233564 [TBL] [Abstract][Full Text] [Related]
5. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373 [TBL] [Abstract][Full Text] [Related]
6. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles. Bian Y; Guo D Drug Des Devel Ther; 2020; 14():647-659. PubMed ID: 32109990 [TBL] [Abstract][Full Text] [Related]
7. Molecular recognition of glyconanoparticles by RCA and E. coli K88 - designing transports for targeted therapy. Gallegos-Tabanico A; Sarabia-Sainz JA; Sarabia-Sainz HM; Carrillo Torres R; Guzman-Partida AM; Monfort GR; Silva-Campa E; Burgara-Estrella AJ; Angulo-Molina A; Acosta-Elias M; Pedroza-Montero M; Vazquez-Moreno L Acta Biochim Pol; 2017; 64(4):671-677. PubMed ID: 29247504 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab') Jin C; Bai L; Lin L; Wang S; Yin X Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1076-1084. PubMed ID: 28776396 [TBL] [Abstract][Full Text] [Related]
9. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery. Salehiabar M; Nosrati H; Javani E; Aliakbarzadeh F; Kheiri Manjili H; Davaran S; Danafar H Int J Biol Macromol; 2018 Aug; 115():83-89. PubMed ID: 29653171 [TBL] [Abstract][Full Text] [Related]
10. Application of galactosylated albumin for targeted delivery of triptolide to suppress hepatocellular carcinoma progression through inhibiting de novo lipogenesis. Yu L; Qian J; Xue X; Pang M; Wang X; Li X; Tian M; Lu C; Xiao C; Liu Y Biomed Pharmacother; 2024 Oct; 179():117432. PubMed ID: 39255735 [TBL] [Abstract][Full Text] [Related]
11. Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapy. Ye PJ; Huang C; Yang S; Gao P; Li ZP; Tang SY; Xiang Y; Liu YF; Chen YP; He DX; Yu CY Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S661-S670. PubMed ID: 30307317 [TBL] [Abstract][Full Text] [Related]
12. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421 [TBL] [Abstract][Full Text] [Related]
13. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles. Zhao P; Li M; Wang Y; Chen Y; He C; Zhang X; Yang T; Lu Y; You J; Lee RJ; Xiang G Acta Biomater; 2018 May; 72():248-255. PubMed ID: 29555460 [TBL] [Abstract][Full Text] [Related]
14. Ultrasmall hybrid protein-copper sulfide nanoparticles for targeted photoacoustic imaging of orthotopic hepatocellular carcinoma with a high signal-to-noise ratio. Yan H; Chen J; Li Y; Bai Y; Wu Y; Sheng Z; Song L; Liu C; Zhang H Biomater Sci; 2018 Dec; 7(1):92-103. PubMed ID: 30358774 [TBL] [Abstract][Full Text] [Related]
15. Novel Albumin Nanoparticle Enhanced the Anti-Insulin-Resistant-Hepatoma Activity of Metformin. Lu Z; Qi L; Lin YR; Sun L; Zhang L; Wang GC; Li JQ; Yu JM Int J Nanomedicine; 2020; 15():5203-5215. PubMed ID: 32801686 [TBL] [Abstract][Full Text] [Related]
16. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma. Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125 [TBL] [Abstract][Full Text] [Related]
17. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma. Huang KW; Lai YT; Chern GJ; Huang SF; Tsai CL; Sung YC; Chiang CC; Hwang PB; Ho TL; Huang RL; Shiue TY; Chen Y; Wang SK Biomacromolecules; 2018 Jun; 19(6):2330-2339. PubMed ID: 29808997 [TBL] [Abstract][Full Text] [Related]
18. Reduced toxicological manifestations of cisplatin following encapsulation in folate grafted albumin nanoparticles. Alam N; Dubey RD; Kumar A; Koul M; Sharma N; Sharma PR; Chandan BK; Singh SK; Singh G; Gupta PN Life Sci; 2015 Dec; 142():76-85. PubMed ID: 26482203 [TBL] [Abstract][Full Text] [Related]
19. Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a Nasr M; Kira AY; Saber S; Essa EA; El-Gizawy SA Mol Pharm; 2023 Sep; 20(9):4758-4769. PubMed ID: 37585079 [TBL] [Abstract][Full Text] [Related]
20. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells. Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]